• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC ANTERALIGN¿ SPINAL SYSTEM WITH TITAN NANOLOCK¿ SURFACE TECHNOLOGY; APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BOD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC ANTERALIGN¿ SPINAL SYSTEM WITH TITAN NANOLOCK¿ SURFACE TECHNOLOGY; APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BOD Back to Search Results
Model Number 4675020
Medical Device Problem Code Difficult to Insert (1316)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 06/18/2024
Type of Reportable Event Serious Injury
Event or Problem Description
Information was received from healthcare provider (hcp) via a manufacturer representative regarding a patient implanted with spacer and screw having l4/5,5/s oblique lateral interbody fusion (olif) therapy for lumbar spinal stenosis.It was reported that l4/5 clyesdale ptc spacer was installed without any issues and l5/s was approached through a separate incision.The procedure progressed smoothly until the retractor was placed, and the cage was installed with 12 degrees.A pilot hole was created, and the bone screw was inserted.However, the screw did not go in smoothly, and the process of creating a pilot hole and inserting the screw was repeated several times.The direction of the screw did not align with the cage's screw hole, so the screw was reinserted using the inserter as a guide, and the screw was eventually installed successfully.Upon removing the screwdriver, bleeding from the left common iliac artery was observed.Hemostasis was achieved by applying a tachosil and compressing for about 15 minutes.Finally, surgiflo was used to ensure hemostasis, the area was irrigated, and it was confirmed that there was no furtherbleeding before closing the wound.Because the issue was noticed early, the intraoperative blood loss was minimal.There was a delay of less than 60 minutes in the overall procedure.There were no further complications reported regarding the event.
 
Additional Manufacturer Narrative
B2: outcome attributed to adverse event- tachosil and surgiflo was used to ensure hemostasis.H6 - neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Annex f code corrected.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTERALIGN¿ SPINAL SYSTEM WITH TITAN NANOLOCK¿ SURFACE TECHNOLOGY
Common Device Name
APPLIANCE, FIXATION, SPINAL INTERVERTEBRAL BOD
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
justin ellis
1800 pyramid place
memphis, TN 38132
7635265677
MDR Report Key19717147
Report Number1030489-2024-00807
Device Sequence Number18179616
Product Code KWQ
UDI-Device Identifier00763000508791
UDI-Public00763000508791
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K212524
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number4675020
Device Catalogue Number4675020
Device Lot NumberRM21J012
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/18/2024
Supplement Date Received by Manufacturer10/24/2024
Initial Report FDA Received Date07/11/2024
Supplement Report FDA Received Date10/24/2024
Date Device Manufactured03/10/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
Patient SexUnknown
-
-